Stevanato Group S.p.A. (NYSE:STVN) Shares Sold by US Bancorp DE

US Bancorp DE reduced its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 7.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,232 shares of the company’s stock after selling 613 shares during the quarter. US Bancorp DE’s holdings in Stevanato Group were worth $145,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in STVN. Hilltop National Bank increased its stake in Stevanato Group by 34.3% in the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after purchasing an additional 1,122 shares during the last quarter. Raymond James Trust N.A. lifted its holdings in shares of Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after acquiring an additional 1,613 shares during the period. First Bank & Trust lifted its holdings in shares of Stevanato Group by 29.1% during the 3rd quarter. First Bank & Trust now owns 14,109 shares of the company’s stock worth $282,000 after acquiring an additional 3,182 shares during the period. Trust Point Inc. boosted its position in shares of Stevanato Group by 16.0% in the third quarter. Trust Point Inc. now owns 23,336 shares of the company’s stock worth $467,000 after acquiring an additional 3,222 shares during the last quarter. Finally, nVerses Capital LLC purchased a new stake in Stevanato Group in the third quarter valued at approximately $84,000.

Stevanato Group Trading Down 7.3 %

STVN opened at €19.00 ($20.00) on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.43) and a 1 year high of €34.73 ($36.56). The firm has a 50 day moving average price of €19.56 and a 200 day moving average price of €20.05.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. During the same period last year, the business earned $0.16 earnings per share. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. Analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Analyst Ratings Changes

Separately, Citigroup lowered their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.